Instituto De Investigación Biomédica De Salamanca
Clinical trials sponsored by Instituto De Investigación Biomédica De Salamanca, explained in plain language.
-
Double-Dose radiation may boost survival in aggressive lung cancer
Disease control Recruiting nowThis study tests whether giving higher doses of radiation twice a day, along with standard chemotherapy, can help people with limited-stage small cell lung cancer live longer without the cancer growing. About 300 adults with early-stage disease that hasn't spread will be randomly…
Phase: PHASE3 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New Gene-Modified immune cells offer hope for tough lymphoma
Disease control Recruiting nowThis early-phase trial tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in the lab to better recognize and attack lymphoma cells.…
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
New software could spare thousands from unnecessary heart procedures
Diagnosis Recruiting nowThis study tests a new computer program that helps doctors diagnose blocked heart arteries more accurately using CT scans. The software automatically detects blockages, measures blood flow, and analyzes plaque. Researchers will compare its results to standard methods in 1,000 pat…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Diagnosis
Last updated Apr 30, 2026 15:51 UTC
-
Personalized exercise prescription aims to boost Seniors' health in rural communities
Symptom relief Recruiting nowThis study tests whether a personalized exercise plan, designed by a primary care team, can improve physical fitness and quality of life for adults aged 65 and older living in rural areas. Participants receive a tailored program including aerobic, strength, balance, and flexibili…
Phase: NA • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC